Remote HbA1c Monitoring: Overcoming the logistical issues and developing innovative care pathways

Description

***THIS IS AN AWARD NOTICE TO CONCLUDE THE PRE-COMMERCIAL PROCUREMENT OF THE COMPETITION DETAILED BELOW. THIS IS NOT A NEW COMPETITION. THE CONTRACTS HAVE BEEN AWARDED BETWEEN THE SUCCESSFUL APPLICANTS AND NHS GOLDEN JUBILEE.*** This is a Pre-Commercial Procurement Award funded by Scottish Government, the Chief Scientific Office (CSO) for diabetes prevention, early detection and monitoring. The award seeks to develop innovative solutions that address person-centred care, improve care pathway and optimise service delivery in HbA1c testing. ***THIS IS AN AWARD NOTICE TO CONCLUDE THE PRE-COMMERCIAL PROCUREMENT OF THE COMPETITION DETAILED BELOW. THIS IS NOT A NEW COMPETITION. CONTRACTS HAVE BEEN AWARDED BETWEEN THE SUCCESSFUL APPLICANTS AND NHS GOLDEN JUBILEE.*** Contracts are between NHS Golden Jubilee and winning participants. Phase 1 projects range in size up to total costs of 20,000 GBP inclusive of VAT. The aim of the award is to develop disruptive innovative solutions that deliver sustainable, accessible and equitable remote HbA1c self-testing. This will include the development, distribution and return of self-collection blood sample kits with instructions on self-phlebotomy for patients and integration of the results within the current NHS infrastructure. Any adoption and implementation of a solution from this competition would be subject to a separate, possibly competitive, procurement exercise. This competition does not cover the purchase of any solution. Contracts have be given to successful applicants.